(Q35090254)

6 August 2017

1 reference

title

Assessment of endothelial damage and dysfunction: observations in relation to heart failure (English)

1 reference

6 August 2017

0 references

0 references

Chong AY

1

1 reference

6 August 2017

Blann AD

series ordinal

2

1 reference

6 August 2017

Lip GY

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

QJM: An International Journal of Medicine

6 August 2017

published in

1 reference

6 August 2017

volume

96

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

253-267

1 reference

von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

St Cyres lecture. Endothelium in control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Normal endothelial cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

A reliable marker of endothelial cell dysfunction: does it exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Up-regulation of thrombomodulin in human umbilical vein endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

von Willebrand factor: clinical features of inherited and acquired disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Influence of ramipril on the course of plasma thrombomodulin in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Cytokines as new treatment targets in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Circulating adhesion molecules in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Von Willebrand factor and soluble E-selectin in hyperlipidaemia: relationship to lipids and vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Circulating cell adhesion molecules and death in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Studies of endothelium-derived relaxant factor (EDRF), its nature and mode of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Endothelial function in chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Large artery function in patients with chronic heart failure. Studies of brachial artery diameter and hemodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Nitric oxide and cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Endothelin-1, endothelin-1 receptors and cardiac natriuretic peptides in failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Early increase precedes a depletion of endothelin-1 but not of von Willebrand factor in cutaneous microvessels of diabetic patients. A quantitative immunohistochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Endothelin in cardiovascular disease: from atherosclerosis to heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Prognostic value of cytokines and neurohormones in severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Endothelin antagonists and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Endothelin in atherosclerosis: importance of risk factors and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Endothelin as a regulator of cardiovascular function in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Hypoxia induces endothelin gene expression and secretion in cultured human endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Comparison of ultrasound assessment of flow-mediated dilatation in the radial and brachial artery with upper and forearm cuff positions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Influence of vessel size, age and body mass index on the flow-mediated dilatation (FMD%) of the brachial artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Prognostic significance of endothelial dysfunction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Endothelium-dependent vasodilation is attenuated in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Chronic ACE inhibition enhances the endothelial control of arterial mechanics and flow-dependent vasodilatation in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Radial artery flow-mediated dilatation in heart failure patients: effects of pharmacological and nonpharmacological treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Effects of cardiac transplantation on endothelium-dependent dilation of the peripheral vasculature in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Effects of low-dose aspirin on endothelial function in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

The relationship between vascular wall shear stress and flow-mediated dilation: endothelial function assessed by phase-contrast magnetic resonance angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG037

21 January 2018

Identifiers

DOI

10.1093/QJMED/HCG037

1 reference

6 August 2017

1 reference